Familial cardiomyopathies: Significant causes of heart failure

Current Cardiology Reports

Volumn 5, Issue 3, 2003, Pages 187-192

  Crispell, Kathy A ^a  

^a Kaiser Sunnyside Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FAMILIAL DISEASE; GENETIC SCREENING; HEART FAILURE; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; MALE; MOLECULAR GENETICS; MORBIDITY; PREVALENCE; REVIEW; CONGESTIVE HEART FAILURE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEART LEFT VENTRICLE FUNCTION;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; HEART FAILURE, CONGESTIVE; HUMANS; PREVALENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038411368     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0047-7     Document Type: Review

References (34)

1. Hunt S, Baker D, Chin M, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2001, 38:2101-2113.
2. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691.
3. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293-302.
4. Packer M, Coats AJ, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651-1658.
5. Goldstein S, Fagerberg B, Hialmarson A, et al.: Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 2001, 38:932-938.
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) Investigators: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999, 353:9-13.
7. Gavazzi A, Repetto A, Scelsi L, et al.: Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy: prevalence, inheritance and characteristics. Eu Heart J 2001, 22:73-81.
8. Baig M, Goldman J, Caforio A, et al.: Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998, 31:195-201.
9. Goerss JB, Michels V, Burnett J, et al.: Frequency of familial dilated cardiomyopathy. Eur Heart J 1995, 16(Suppl O):2.
10. Grunig E, Tasman T, Kucherer H, et al.: Frequency and pheno-types of familial dilated cardiomyopathy. J Am Coll Cardiol 1998, 31:186-194.
11. Mestroni L, Rocco C, Gregori D, et al.: Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 1999, 34:181-190.
12. Seidman JG, Seidman C: The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557-567.
13. Crispell K, Wray A, Ni H, et al.: Clinical profiles of four large pedigrees with familial dilated cardiomyopathy. J Am Coll Cardiol 1999, 34:837-847.
14. Crispell K, Hanson E, Coates K, et al.: Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy. J Am Coll Cardiol 2002, 39:1503-1507.
15. Arbustini E, Pilotto A, Repetto A, et al.: Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002, 39:981-990.
16. Arbustini E, Morbini P, Pilotto A, et al.: Familial dilated cardiomyopathy: from clinical presentation to molecular genetics. Eur Heart J 2000, 21:1825-1832.
17. Mestroni L, Maisch B, McKenna W, et al.: Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 1999, 20:93-102.
18. Arbustini E, Diegoli M, Morbini P, et al.: Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 2000, 35:1760-1768.
19. Mahon N, Madden B, Caforio A, et al.: Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002, 39:455-462.
20. Krajinovic M, Pinamonti B, Sinagra G, et al.: Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Genet 1995, 57:846-852.
21. Bilinska Z, Michalak E, Grzybowski J, et al.: Left ventricular enlargement in relatives of dilated cardiomyopathy patients: indication for early angiotensin-converting enzyme inhibition? Eu Heart J 1999, 20:360.
22. Kamisago M, Sharma S, DePalma S, et al.: Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000, 343:1688-1696.
23. Villard E, Duboscq-Bidot L, Peuchmaurd M, et al.: Cardiac myosin heavy chain mutations are frequently observed in dilated cardiomyopathy. Circulation 2002, 106:II-60.
24. Maron B: Hypertrophic cardiomyopathy. Circulation 2002, 106:2419-2421.
25. Li D, Czernuszewicz G, Gonzalez O, et al.: Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001, 104:2188-2193.
26. Regitz-Zagrosek V, Erdmann J, Wellnhofer E, et al.: Novel mutation in the _-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation 2000, 102:1-5.
27. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H, et al.: Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene. Heart 1996, 76:63-65.
28. Kokado H, Shimizu M, Yoshio H, et al.: Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 2000, 102:663-669.
29. McConnell B, Jones K, Fatkin D, et al.: Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 1999, 104:1235-1244.
30. Corrado D, Fontaine G, Marcus F, et al.: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation 2000, 101:E101-E106.
31. Nava A, Bauce B, Basso C, et al.: Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000, 36:2226-2233.
32. Alcalai R, Metzger S, Rosenheck S, et al.: A recessive mutation in the desmoplakin gene causes arrhythmogenic right ventricular dysplasia, skin disorder and wooly hair. Circulation 2002, 106:II-203.
33. Angelini A, Calzolari V, Thiene G, et al.: Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol 1997, 80:1046-1050.
34. Mogensen J, Kubo T, Duque M, et al.: Restrictive cardiomyopathy is caused by mutations in the gene for cardiac troponin I. Circulation 2002, 106:II-60.